HR 8763 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To direct the Secretary of Veterans Affairs to furnish stellate ganglion block to veterans with post-traumatic stress disorder, and for other purposes.
Summary
The TREAT PTSD VA Act directs the Department of Veterans Affairs to provide stellate ganglion block treatment to enrolled veterans with post-traumatic stress disorder who elect to receive it after being informed of the risks and benefits. The treatment may be provided through VA medical facilities or other healthcare providers. The Department must update its clinical practice guideline for PTSD management within 180 days to include stellate ganglion block as a therapy option and provide information on clinical indicators and contraindicators. The changes take effect 180 days after the law's enactment.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Perry, Scott [R-PA-10] (R-PA)
Money behind the sponsor
Top reported contributors to Scott Perry’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- BRODIE GENERATIONAL CAPITAL PARTNERS $13,200
- SAULSBURY INDUSTRIES $13,200
- COMMONWEALTH OF PA $8,350
- NULL $7,326
- FOUR SEASONS PRODUCE $7,300
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Scott Perry → · Outside spending →
Actions (2)
- May 12, 2026 Referred to the House Committee on Veterans' Affairs. · house
- May 12, 2026 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE HOUSE OF REPRESENTATIVES
May 12, 2026
Mr. Perry introduced the following bill; which was referred to the Committee on Veterans’ Affairs
A BILL
To direct the Secretary of Veterans Affairs to furnish stellate ganglion block to veterans with post-traumatic stress disorder, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Treatment and Relief through Emerging and Accessible Therapy for PTSD VA Act” or the “TREAT PTSD VA Act”.
SEC. 2. PROVISION OF STELLATE GANGLION BLOCK TO VETERANS WITH POST- TRAUMATIC STRESS DISORDER.
(a) Provision to Veterans.—
(1) In general.—Subchapter II of chapter 17 of title 38, United States Code, is amended by adding at the end the following new section: “Sec. 1720M. Provision of stellate ganglion block for certain veterans
“(a) In General.—The Secretary shall furnish stellate ganglion block to any veteran who—
“(1) is enrolled in the patient enrollment system under section 1705 of this title;
“(2) has been diagnosed with post-traumatic stress disorder; and
“(3) has elected to receive stellate ganglion block after being informed by a qualified health care provider of the risks and benefits of stellate ganglion block.
“(b) Provision of Care.—The Secretary may furnish stellate ganglion block under subsection (a) through a medical facility of the Department or through a health care provider specified in section 1703(c) of this title.”.
(2) Clerical amendment.—The table of contents at the beginning of chapter 17 of title 38, United States Code, is amended by inserting after the item relating to section 1720L the following new item:
“1720M. Provision of stellate ganglion block for certain veterans.”.
(b) Update of Joint Clinical Practice Guideline.—
(1) Update of guideline.—Not later than 180 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall update the guideline titled the “VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD” (or such successor guideline) to ensure the guideline—
(A) reflects the availability of stellate ganglion block as a therapy option; and
(B) includes information on the clinical indicators and contraindicators for such therapy option.
(2) Notification.—Upon updating the guideline under paragraph (1), the Secretary shall notify the Committees on Veterans’ Affairs of the House of Representatives and the Senate of such update.
(c) Effective Date.—The amendment made by subsection (a) shall take effect on the date that is 180 days after the date of the enactment of this Act. <all>
Comments